PureTech Health plc (OTCMKTS:PTCHF) Sees Large Drop in Short Interest

PureTech Health plc (OTCMKTS:PTCHF) was the target of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totaling 36,518 shares, a decrease of 16.1% from the November 30th total of 43,518 shares. Based on an average daily volume of 974 shares, the short-interest ratio is currently 37.5 days. Based on an average daily volume of 974 shares, the short-interest ratio is currently 37.5 days.

PureTech Health Stock Performance

PureTech Health stock opened at $1.71 on Wednesday. PureTech Health has a 1 year low of $1.27 and a 1 year high of $1.90. The firm’s 50 day moving average price is $1.67 and its two-hundred day moving average price is $1.69.

PureTech Health Company Profile

PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.

The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.